Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome With Excess Blasts-1”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Study completedNCT02220985
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+20 more
Fred Hutchinson Cancer Center 84
Testing effectiveness (Phase 2)Looking for participantsNCT03779854
What this trial is testing

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+14 more
Fred Hutchinson Cancer Center 68
Not applicableUnknownNCT02850822
What this trial is testing

Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT

Who this might be right for
Myelodysplastic SyndromeChemotherapy
Nanfang Hospital, Southern Medical University 250
Early research (Phase 1)Study completedNCT01139151
What this trial is testing

4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 31
Early research (Phase 1)Ended earlyNCT00458159
What this trial is testing

A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndrome
Celgene 34
Early research (Phase 1)Study completedNCT00111683
What this trial is testing

MK0457 in Patients With Leukemia (0457-003)

Who this might be right for
Chronic Myelogenous Leukemia in Blast CrisisLymphocytic Leukemia, B Cell, AcuteMyelodysplastic Syndromes+1 more
Merck Sharp & Dohme LLC 28
Testing effectiveness (Phase 2)UnknownNCT06247917
What this trial is testing

Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS

Who this might be right for
Myelodysplastic Syndrome With Excess Blasts-1Myelodysplastic Syndrome With Excess Blasts-2Myelodysplastic Syndromes
Ruijin Hospital 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976
What this trial is testing

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more
National Cancer Institute (NCI) 282
Early research (Phase 1)Active Not RecruitingNCT02530034
What this trial is testing

Hu8F4 in Treating Patients With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveHematopoietic and Lymphoid Cell Neoplasm+8 more
M.D. Anderson Cancer Center 72
Large-scale testing (Phase 3)Study completedNCT02744742
What this trial is testing

G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Who this might be right for
Myelodysplastic SyndromeAllogeneic Hematopoietic Stem Cell TransplantationConditioning
Nanfang Hospital, Southern Medical University 202
Testing effectiveness (Phase 2)Study completedNCT01858740
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+15 more
Fred Hutchinson Cancer Center 20
Large-scale testing (Phase 3)UnknownNCT04713956
What this trial is testing

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Who this might be right for
Myelodysplastic SyndromeAllogeneic Hematopoietic Stem Cell TransplantationConditioning
Nanfang Hospital, Southern Medical University 242
Testing effectiveness (Phase 2)Looking for participantsNCT05805605
What this trial is testing

Allo HSCT Using RIC and PTCy for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more
Masonic Cancer Center, University of Minnesota 56
Testing effectiveness (Phase 2)Study completedNCT01012492
What this trial is testing

Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

Who this might be right for
AMLALLUndifferentiated Leukemia+9 more
Boston Children's Hospital 11
Early research (Phase 1)Study completedNCT00533416
What this trial is testing

Safety of ON 01910.Na in Patients With Myelodysplasia

Who this might be right for
Myelodysplastic Syndrome (MDS)
National Heart, Lung, and Blood Institute (NHLBI) 14
Not applicableStudy completedNCT00426205
What this trial is testing

GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies

Who this might be right for
Myelodysplastic Syndrome RAEB-I or RAEB-IIRefractory Acute Myeloid LeukemiaRefractory CML Myeloid Blast Crisis
Dana-Farber Cancer Institute 28